CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells

Acta Pharmacol Sin. 2006 Apr;27(4):414-8. doi: 10.1111/j.1745-7254.2006.00294.x.

Abstract

Aim: To investigate the modulatory effect of CJZ3, a lomerizine derivative, on P-glycoprotein (P-gp) function in rat brain microvessel endothelial cells (RBMEC).

Methods: RBMEC were isolated and cultured in Dulbecco modified Eagle medium/F12 (1:1) medium, and the amount of intracellular rhodamine 123 (Rh123) was determined using a fluorescence spectrophotometer to evaluate the modulatory effect of CJZ3 on P-gp function.

Results: The accumulation of Rh123 was potentiated in a concentration-dependent manner after incubation with CJZ3 for RBMEC, but not for human umbilical vein endothelial cells (HUVEC). CJZ3 caused the accumulation of intracellular Rh123 in a time-dependent manner and significantly decreased the efflux of Rh123 from the cells. The inhibitory effect of CJZ3 on P-gp function was reversible and remained for 120 min after CJZ3 (2.5 micromol/L) was removed from the medium.

Conclusion: CJZ3 has a potent in vitro effect on the inhibition of P-gp function.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Animals
  • Brain / blood supply*
  • Calcium Channel Blockers / administration & dosage
  • Calcium Channel Blockers / pharmacology*
  • Dose-Response Relationship, Drug
  • Endothelial Cells / metabolism*
  • Humans
  • Microcirculation / cytology
  • Molecular Structure
  • Piperazines / administration & dosage
  • Piperazines / chemistry
  • Piperazines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Rhodamine 123 / metabolism

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Calcium Channel Blockers
  • Piperazines
  • Rhodamine 123
  • lomerizine